7
3

End Prescription Drug Ads Now Act

7/7/2025, 1:35 PM

Summary of Bill S 2068

This bill, designated as S. 2068 in the 119th Congress and introduced on June 12, 2025, aims to prohibit drug manufacturers from utilizing direct-to-consumer advertising, encompassing platforms like social media, to market their products.

Current Status of Bill S 2068

Bill S 2068 is currently in the status of Bill Introduced since June 12, 2025. Bill S 2068 was introduced during Congress 119 and was introduced to the Senate on June 12, 2025.  Bill S 2068's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of June 12, 2025

Bipartisan Support of Bill S 2068

Total Number of Sponsors
4
Democrat Sponsors
0
Republican Sponsors
0
Unaffiliated Sponsors
4
Total Number of Cosponsors
11
Democrat Cosponsors
9
Republican Cosponsors
0
Unaffiliated Cosponsors
2

Policy Area and Potential Impact of Bill S 2068

Primary Policy Focus

Health

Alternate Title(s) of Bill S 2068

A bill to ban drug manufacturers from using direct-to-consumer advertising, including social media, to promote their products.
A bill to ban drug manufacturers from using direct-to-consumer advertising, including social media, to promote their products.

Comments

Jensen Rosenthal profile image

Jensen Rosenthal

634

8 months ago

I fully support this bill. It's about time we put a stop to the constant bombardment of drug advertisements on social media. But how will this impact the pharmaceutical industry in the short term?

Michaela Harding profile image

Michaela Harding

577

8 months ago

This bill good. How this affect me in long run?